The Company is a Korea-based company mainly engaged in the manufacture and sale of biological products. The Company s main products include vaccines such as SKYCellflu and Rotatech. The Company also sells infusion solutions. In addition, the Company engages in technology export business. The Company sells its products in domestic and overseas markets. The Company was founded on July 1, 2018 and its shares are listed on Korea Stock Exchange on March 18, 2021.
Headquarters
310, Pangyo-Ro, Bundang-Gu
Seongnam; Gyeonggi;
Contact Details: Purchase the Sk Bio Science Co.,Ltd. report to view the information.
Website: http://www.skbioscience.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service